Company Intelligence

Nephrogen

Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases.

Official Website
In this profile

Quick Facts

  • Founded 2025
  • Headquarters New York City, Americas
  • Country Americas
  • Industry AI in Enterprise Software
  • Company Type Techstars New York City Accelerator
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases.

Why It Matters

Nephrogen appears in the public Techstars New York City Accelerator portfolio (open accelerator dataset).

Recent Developments

  1. 2025 Company founded

    Nephrogen was founded in 2025 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

AI in Enterprise Software Open industry

Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Request a correction if you represent this company or believe information is inaccurate.

Explore Related Intelligence

Products Product directory Founders Founder profiles Reports Open reports Industries Explore sectors

The AI Brief

Weekly company intelligence in your inbox.

Subscribe